Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Malignant melanoma of the choroid: treatment with episcleral /sup 198/Au plaque and xenon-arc photocoagulation

Journal Article · · Ann. Ophthalmol.; (United States)
OSTI ID:5176924
A method of treatment for posteriorly located malignant melanomas of the choroid is reviewed. Twenty-six patients have been treated either by radioactive gold (/sup 198/Au) seed radiation plaque, alone or in combination with postradiation xenon-arc photocoagulation. Success, defined as the preservation of the globe with tumor ablated or regressed, was achieved in 92.3% of the treated eyes. These patients have been followed from 1 to 8.5 years, with an average follow-up of 44.84 months. Fifteen out of 26 patients (57.69%) had a final visual acuity of 20/50 or better. The main complications were radiation retinopathy (19.2%) and cystoid macular edema (19.2%). There were two enucleations, one after 29 months and one after 24 months following treatment.
Research Organization:
Baylor College of Medicine, Houston, TX
OSTI ID:
5176924
Journal Information:
Ann. Ophthalmol.; (United States), Journal Name: Ann. Ophthalmol.; (United States) Vol. 2; ISSN ANOPB
Country of Publication:
United States
Language:
English